222 related articles for article (PubMed ID: 22496648)
1. Human nasal challenge with Streptococcus pneumoniae is immunising in the absence of carriage.
Wright AK; Ferreira DM; Gritzfeld JF; Wright AD; Armitage K; Jambo KC; Bate E; El Batrawy S; Collins A; Gordon SB
PLoS Pathog; 2012; 8(4):e1002622. PubMed ID: 22496648
[TBL] [Abstract][Full Text] [Related]
2. The immunising effect of pneumococcal nasopharyngeal colonisation; protection against future colonisation and fatal invasive disease.
Richards L; Ferreira DM; Miyaji EN; Andrew PW; Kadioglu A
Immunobiology; 2010 Apr; 215(4):251-63. PubMed ID: 20071053
[TBL] [Abstract][Full Text] [Related]
3. The nasal dendritic cell-targeting Flt3 ligand as a safe adjuvant elicits effective protection against fatal pneumococcal pneumonia.
Kataoka K; Fujihashi K; Oma K; Fukuyama Y; Hollingshead SK; Sekine S; Kawabata S; Ito HO; Briles DE; Oishi K
Infect Immun; 2011 Jul; 79(7):2819-28. PubMed ID: 21536790
[TBL] [Abstract][Full Text] [Related]
4. Poor association between 13-valent pneumococcal conjugate vaccine-induced serum and mucosal antibody responses with experimental Streptococcus pneumoniae serotype 6B colonisation.
Tembo G; Mayuni M; Kamng'ona R; Chimgoneko L; Chiwala G; Sichone S; Galafa B; Thole F; Mkandawire C; Chirwa AE; Nsomba E; Nkhoma V; Ngoliwa C; Toto N; Makhaza L; Muyaya A; Kudowa E; Henrion MYR; Dula D; Morton B; Chikaonda T; Gordon SB; Jambo KC
Vaccine; 2024 Apr; 42(12):2975-2982. PubMed ID: 38570270
[TBL] [Abstract][Full Text] [Related]
5. Controlled human infection and rechallenge with Streptococcus pneumoniae reveals the protective efficacy of carriage in healthy adults.
Ferreira DM; Neill DR; Bangert M; Gritzfeld JF; Green N; Wright AK; Pennington SH; Bricio-Moreno L; Moreno AT; Miyaji EN; Wright AD; Collins AM; Goldblatt D; Kadioglu A; Gordon SB
Am J Respir Crit Care Med; 2013 Apr; 187(8):855-64. PubMed ID: 23370916
[TBL] [Abstract][Full Text] [Related]
6. Experimental human pneumococcal carriage augments IL-17A-dependent T-cell defence of the lung.
Wright AK; Bangert M; Gritzfeld JF; Ferreira DM; Jambo KC; Wright AD; Collins AM; Gordon SB
PLoS Pathog; 2013 Mar; 9(3):e1003274. PubMed ID: 23555269
[TBL] [Abstract][Full Text] [Related]
7. Host immunity in the protective response to nasal immunization with a pneumococcal antigen associated to live and heat-killed Lactobacillus casei.
Vintiñi EO; Medina MS
BMC Immunol; 2011 Aug; 12():46. PubMed ID: 21834957
[TBL] [Abstract][Full Text] [Related]
8. Intranasal immunization with heat-inactivated Streptococcus pneumoniae protects mice against systemic pneumococcal infection.
Hvalbye BK; Aaberge IS; Løvik M; Haneberg B
Infect Immun; 1999 Sep; 67(9):4320-5. PubMed ID: 10456869
[TBL] [Abstract][Full Text] [Related]
9. Mucosal immunization with an unadjuvanted vaccine that targets Streptococcus pneumoniae PspA to human Fcγ receptor type I protects against pneumococcal infection through complement- and lactoferrin-mediated bactericidal activity.
Bitsaktsis C; Iglesias BV; Li Y; Colino J; Snapper CM; Hollingshead SK; Pham G; Gosselin DR; Gosselin EJ
Infect Immun; 2012 Mar; 80(3):1166-80. PubMed ID: 22158740
[TBL] [Abstract][Full Text] [Related]
10. Intranasal immunization with recombinant PspA fused with a flagellin enhances cross-protective immunity against Streptococcus pneumoniae infection in mice.
Nguyen CT; Kim SY; Kim MS; Lee SE; Rhee JH
Vaccine; 2011 Aug; 29(34):5731-9. PubMed ID: 21696869
[TBL] [Abstract][Full Text] [Related]
11. Mucosal immune responses to capsular pneumococcal polysaccharides in immunized preschool children and controls with similar nasal pneumococcal colonization rates.
Zhang Q; Arnaoutakis K; Murdoch C; Lakshman R; Race G; Burkinshaw R; Finn A
Pediatr Infect Dis J; 2004 Apr; 23(4):307-13. PubMed ID: 15071283
[TBL] [Abstract][Full Text] [Related]
12. Increased IgG but normal IgA anti-pneumococcal protein antibodies in lung of HIV-infected adults.
Collins AM; Batrawy SE; Gordon SB; Ferreira DM
Vaccine; 2013 Aug; 31(35):3469-72. PubMed ID: 23664995
[TBL] [Abstract][Full Text] [Related]
13. Nasal vaccination with pneumococcal surface protein A in combination with cationic liposomes consisting of DOTAP and DC-chol confers antigen-mediated protective immunity against Streptococcus pneumoniae infections in mice.
Tada R; Suzuki H; Takahashi S; Negishi Y; Kiyono H; Kunisawa J; Aramaki Y
Int Immunopharmacol; 2018 Aug; 61():385-393. PubMed ID: 29945026
[TBL] [Abstract][Full Text] [Related]
14. Polysaccharide-Specific Memory B Cells Predict Protection against Experimental Human Pneumococcal Carriage.
Pennington SH; Pojar S; Mitsi E; Gritzfeld JF; Nikolaou E; Solórzano C; Owugha JT; Masood Q; Gordon MA; Wright AD; Collins AM; Miyaji EN; Gordon SB; Ferreira DM
Am J Respir Crit Care Med; 2016 Dec; 194(12):1523-1531. PubMed ID: 27403678
[TBL] [Abstract][Full Text] [Related]
15. Protection elicited by nasal immunization with pneumococcal surface protein A (PspA) adjuvanted with bacterium-like particles against Streptococcus pneumoniae infection in mice.
Li B; Chen X; Yu J; Zhang Y; Mo Z; Gu T; Kong W; Wu Y
Microb Pathog; 2018 Oct; 123():115-119. PubMed ID: 29959043
[TBL] [Abstract][Full Text] [Related]
16. Nasal immunization with the 40-kDa outer membrane protein of Porphyromonas gingivalis plus cholera toxin induces protective immunity in aged mice.
Cai Y; Kurita-Ochiai T; Kobayashi R; Hashizume T; Yamamoto M
J Oral Sci; 2013; 55(2):107-14. PubMed ID: 23748449
[TBL] [Abstract][Full Text] [Related]
17. Oral immunization with PspA elicits protective humoral immunity against Streptococcus pneumoniae infection.
Yamamoto M; McDaniel LS; Kawabata K; Briles DE; Jackson RJ; McGhee JR; Kiyono H
Infect Immun; 1997 Feb; 65(2):640-4. PubMed ID: 9009325
[TBL] [Abstract][Full Text] [Related]
18. Experimental Human Pneumococcal Colonization in Older Adults Is Feasible and Safe, Not Immunogenic.
Adler H; German EL; Mitsi E; Nikolaou E; Pojar S; Hales C; Robinson R; Connor V; Hill H; Hyder-Wright AD; Lazarova L; Lowe C; Smith EL; Wheeler I; Zaidi SR; Jochems SP; Loukov D; Reiné J; Solórzano-Gonzalez C; de Gorguette d'Argoeuves P; Jones T; Goldblatt D; Chen T; Aston SJ; French N; Collins AM; Gordon SB; Ferreira DM; Rylance J
Am J Respir Crit Care Med; 2021 Mar; 203(5):604-613. PubMed ID: 32941735
[No Abstract] [Full Text] [Related]
19. Mucosal immunization with polyamine transport protein D (PotD) protects mice against nasopharyngeal colonization with Streptococcus pneumoniae.
Shah P; Briles DE; King J; Hale Y; Swiatlo E
Exp Biol Med (Maywood); 2009 Apr; 234(4):403-9. PubMed ID: 19176871
[TBL] [Abstract][Full Text] [Related]
20. Protection Elicited by Nasal Immunization with Recombinant Pneumococcal Surface Protein A (rPspA) Adjuvanted with Whole-Cell Pertussis Vaccine (wP) against Co-Colonization of Mice with Streptococcus pneumoniae.
Tostes RO; Rodrigues TC; da Silva JB; Schanoski AS; Oliveira ML; Miyaji EN
PLoS One; 2017; 12(1):e0170157. PubMed ID: 28103277
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
